XML 73 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Shareholders' capital (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Number of Common Shares
Number of common shares 
20202019
Common shares, beginning of year524,223,323 488,851,433 
Public offering66,130,063 28,009,341 
Dividend reinvestment plan5,217,071 6,068,465 
Exercise of share-based awards (b)1,565,537 1,274,655 
Conversion of convertible debentures6,225 19,429 
Common shares, end of year597,142,219 524,223,323 
Schedule of Shares Issued and Outstanding
The Company has the following Series A and Series D preferred shares issued and outstanding as at December 31, 2020 and 2019:
Preferred sharesNumber of sharesPrice per shareCarrying amount C$Carrying amount $
Series A4,800,000 C$25 C$116,546 $100,463 
Series D4,000,000 C$25 C$97,259 $83,836 
$184,299 
Share-based Compensation Expense
For the year ended December 31, 2020, AQN recorded $24,637 (2019 - $11,042) in total share-based compensation expense as follows: 
20202019
Share options$1,743 $1,288 
Director deferred share units870 798 
Employee share purchase511 322 
Performance and restricted share units21,513 8,634 
Total share-based compensation$24,637 $11,042 
Fair Value of Share Options Granted
The following assumptions were used in determining the fair value of share options granted: 
20202019
Risk-free interest rate1.2 %1.9 %
Expected volatility24 %20 %
Expected dividend yield4.1 %4.3 %
Expected life5.50 years5.50 years
Weighted average grant date fair value per optionC$2.72 C$1.66 
Stock Option Activity
Share option activity during the years is as follows: 
Number of
awards
Weighted
average
exercise
price
Weighted
average
remaining
contractual
term (years)
Aggregate
intrinsic
value
Balance, January 1, 20196,292,642 C$11.61 5.75C$13,342 
Granted1,113,775 14.96 8.00— 
Exercised(3,882,505)11.23 4.456,225 
Balance, December 31, 20193,523,912 C$13.09 5.87C$18,609 
Granted999,962 16.78 7.27 
Exercised(2,386,275)12.52 5.1618,465 
Forfeited(27,151)14.96  
Balance, December 31, 20202,110,448 C$15.45 6.55C$11,604 
Exercisable, December 31, 20201,710,662 C$15.22 6.44C$9,798 
Performance Stock Units
A summary of the PSUs and RSUs follows: 
Number of awardsWeighted
average
grant-date
fair value
Weighted
average
remaining
contractual
term (years)
Aggregate
intrinsic
value
Balance, January 1, 20191,392,132 C$12.75 1.60C$19,114 
Granted, including dividends1,471,442 14.69 2.0016,302 
Exercised(344,340)11.55 — 5,148 
Forfeited(107,191)13.84 — — 
Balance, December 31, 20192,412,043 C$14.00 1.86C$44,309 
Granted, including dividends1,313,171 19.31 2.0024,966 
Exercised(968,470)14.45  20,105 
Forfeited(35,537)15.62  745 
Balance, December 31, 20202,721,207 C$16.58 0.93C$44,289 
Exercisable, December 31, 2020707,630 C$12.70  C$14,825